Prev：Highly sensitive single-molecule counting technology for cytokeratin 18 detection in non-alcoholic fatty liver disease using novel antibodies(A21210-4.80)
Next：The potential role of differentially expressed tRNA-derived fragments in high glucose-induced podocytes(A21020-3.00)
